الصفحة الرئيسية>>Lipids>> Fatty Acids>>10(E),12(Z)-Conjugated Linoleic Acid

10(E),12(Z)-Conjugated Linoleic Acid (Synonyms: 10E,12ZCLA)

رقم الكتالوجGC40396

Conjugated linoleic acid (CLA) refers to a family of 8 geometric isomers of linoleic acid in which the two double bonds are contiguous.

Products are for research use only. Not for human use. We do not sell to patients.

10(E),12(Z)-Conjugated Linoleic Acid التركيب الكيميائي

Cas No.: 2420-56-6

الحجم السعر المخزون الكميّة
5mg
117٫00
متوفر
10mg
167٫00
متوفر
25mg
265٫00
متوفر
50mg
473٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Conjugated linoleic acid (CLA) refers to a family of 8 geometric isomers of linoleic acid in which the two double bonds are contiguous. (The predominant form of linoleic acid in nature, 18:ω6, has double bonds at 9 and 12, interrupted by a methylene carbon.) CLA is found in both meat and dairy products, but it is not found to any significant degree in plants. The predominant isomer of CLA in animal tissue is 9Z,11E; smaller amounts of 10E,12Z also occur. Various antioxidant and antitumor activities have been attributed to CLA or its downstream metabolites. Reported health benefits of dietary supplementation with CLA have been attributed variously to competitive inhibition of δ6-desaturase and/or PPARγ activation.

مراجعات

Review for 10(E),12(Z)-Conjugated Linoleic Acid

Average Rating: 5 ★★★★★ (Based on Reviews and 22 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 10(E),12(Z)-Conjugated Linoleic Acid

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.